Literature DB >> 12468146

Combined platinum containing treatment in NSCLC.

Lucio Crinò1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12468146     DOI： 10.1016/s0169-5002(02)00269-6

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  1 in total

1.  A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors.

Authors:  Laura Q M Chow; S Gail Eckhardt; Cindy L O'Bryant; Mary Kay Schultz; Mark Morrow; Stacy Grolnic; Michele Basche; Lia Gore
Journal:  Cancer Chemother Pharmacol       Date:  2007-12-06       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.